Novel Coronavirus (SARS-CoV-2/COVID-19)
The FDA granted full approval of Pfizer’s COVID-19 vaccine for young teens, covering the age group spanning 12 to 15 years old
Since the onset of the COVID pandemic in 2020, health care has faced many workforce challenges in delivering patient care, including staffing shortages and clinician burnout in the face of unrelenting demand.
The seven-day average of daily hospitalization due to COVID-19 is up nearly 24% over the previous month, according to data from the Centers for Disease Control and Prevention and state health departments. During the seven-day period ending over the July 4 holiday weekend, CDC reported nearly 30,000…
America’s hospitals and health systems continue to face unprecedented financial pressures due to the ongoing effects of the COVID-19 pandemic and current inflationary economy. Historic inflation has extended and heightened the already severe economic instability brought on by the pandemic resulting…
The FDA last week revised its Evusheld fact sheet for health care providers, recommending repeat dosing every six months if patients need ongoing protection.
The Living Learning Network’s pandemic reflection book showcases the defining moments of COVID-19 as told by the front lines.
The AHA has been collecting resources to assist organizations in their efforts to plan for the future post-COVID-19 workforce.
Seattle Children’s Hospital is taking a collaborative approach with parents to vaccinate very young children against COVID-19
The Food and Drug Administration today announced it has revoked the emergency use authorizations for the Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test and Simoa SARS-CoV-2 N Protein Antigen Test.
The CDC endorsed Moderna’s COVID-19 vaccine for children aged 6-17.